SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+7.05%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$427M
AUM Growth
+$427M
(+54%)
Cap. Flow
+$139M
Cap. Flow
% of AUM
32.43%
Top 10 Holdings %
Top 10 Hldgs %
57.06%
Holding
143
New
47
Increased
27
Reduced
21
Closed
35
Top Buys
| 1 |
Novartis
NVS
|
$42.9M |
| 2 |
Sanofi
SNY
|
$33.4M |
| 3 |
Johnson & Johnson
JNJ
|
$21.2M |
| 4 |
Eli Lilly
LLY
|
$17.7M |
| 5 |
Merck
MRK
|
$14.2M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$9.18M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$7.75M |
| 3 |
Invesco QQQ Trust
QQQ
|
$7.1M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$4.67M |
| 5 |
Apple
AAPL
|
$3.1M |
Sector Composition
| 1 | Healthcare | 75.14% |
| 2 | Consumer Discretionary | 3.07% |
| 3 | Technology | 2.73% |
| 4 | Industrials | 1.88% |
| 5 | Consumer Staples | 1.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDMO
76
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.22M | 0.28% |
+640,000
| New | +$1.22M |
|
77
Nektar Therapeutics
NKTR
$537M
| $1.21M | 0.28% |
+100,000
| New | +$1.21M |
|
78
Omeros
OMER
$282M
| $1.21M | 0.28% |
+100,000
| New | +$1.21M |
|
79
Xencor
XNCR
$581M
| $1.17M | 0.27% |
100,000
-48,000
| -32% | -$563K |
|
80
MacroGenics
MGNX
$123M
| $1.14M | 0.26% |
+41,000
| New | +$1.14M |
|
|
QLTI
81
DELISTED
QLT Inc
QLTI
| $1.11M | 0.25% |
200,000
| – | – |
|
|
WINT
82
DELISTED
Windtree Therapeutics Inc
WINT
| $1.08M | 0.25% |
500,000
| – | – |
|
|
SRCL
83
DELISTED
Stericycle Inc
SRCL
| $1.07M | 0.24% |
9,439
-18,700
| -66% | -$2.12M |
|
84
Vanda Pharmaceuticals
VNDA
$281M
| $1.06M | 0.24% |
65,000
-30,000
| -32% | -$487K |
|
85
Tonix Pharmaceuticals
TNXP
$243M
| $1.04M | 0.24% |
+100,000
| New | +$1.04M |
|
86
Ellomay Capital Ltd
ELLO
$231M
| $995K | 0.23% |
100,853
+1,900
| +2% | +$18.7K |
|
|
KBIO
87
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
| $976K | 0.22% |
360,000
-25,000
| -6% | -$67.8K |
|
|
ALBO
88
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $775K | 0.18% |
+283,900
| New | +$775K |
|
89
Compugen
CGEN
$134M
| $726K | 0.17% |
+69,109
| New | +$726K |
|
90
Ormat Technologies
ORA
$5.51B
| $704K | 0.16% |
+23,472
| New | +$704K |
|
|
XLRN
91
DELISTED
Acceleron Pharma Inc.
XLRN
| $690K | 0.16% |
20,000
-30,000
| -60% | -$1.04M |
|
92
F5
FFIV
$17.5B
| $663K | 0.15% |
+6,222
| New | +$663K |
|
|
HSTO
93
DELISTED
Histogen Inc. Common Stock
HSTO
| $651K | 0.15% |
80,000
-7,600
| -9% | -$61.8K |
|
|
IMGN
94
DELISTED
Immunogen Inc
IMGN
| $515K | 0.12% |
+34,500
| New | +$515K |
|
95
Caesarstone
CSTE
$49.4M
| $426K | 0.1% |
+7,830
| New | +$426K |
|
|
FRTX
96
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $387K | 0.09% |
+300,000
| New | +$387K |
|
|
97
Apple
AAPL
$3.51T
| – | – |
-5,520
| Closed | -$3.1M |
|
98
Acadia Pharmaceuticals
ACAD
$4.31B
| – | – |
-60,000
| Closed | -$1.5M |
|
99
Achieve Life Sciences
ACHV
$147M
| – | – |
-74,100
| Closed | -$618K |
|
100
Arrowhead Research
ARWR
$3.71B
| – | – |
-20,000
| Closed | -$217K |
|